Committed to sharing our science

Committed to sharing our science

358 results available

Concomitant Aficamten and Disopyramide in Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy

Oral Presentation, ACC 2025

Masri, A et al.

March 31, 2025
Reldesemtiv in Amyotrophic Lateral Sclerosis: Results From the COURAGE-ALS Randomized Clinical Trial

JAMA Neurology

Shefner, JM et al

March 24, 2025
A Characterization of the Nonclinical Pharmacology and Toxicology of Aficamten, a Reversible Allosteric Inhibitor of Cardiac Myosin

International Journal of Toxicology

Pugsley, MK et al

March 20, 2025
Effect of Hepatic Impairment or Renal Impairment on the Pharmacokinetics of Aficamten

Clinical Pharmacokinetics

Xu, D et al

February 5, 2025
Aficamten vs Metoprolol for Obstructive Hypertrophic Cardiomyopathy: MAPLE-HCM Rationale, Study Design, and Baseline Characteristics

Journal of the American College of Cardiology: Heart Failure

Garcia-Pavia, P et al

February 3, 2025